You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日速報》恆指半日收報21,896點 升157點; 恆生科技指數半日收報4,560點 升6點 藥明生物升逾6% 聯通、國壽、康基醫療、亞盛醫藥、綠葉製藥創新高
恆指半日收21,896點,升157點或0.7%。恆生科技指數報4,560點,升6點或0.1%。國指升24點或0.3%,報7,415點。 活躍重磅股表現: 美團(03690.HK) 收166.5元,下跌2.7%; 阿里巴巴(09988.HK) 收113.8元,上升1%; 騰訊(00700.HK) 收374.6元,上升0.9%; 平安(02318.HK) 收62.55元,上升0.6%; 友邦(01299.HK) 收88.3元,上升0.4%; 港交所(00388.HK) 收369.2元,上升0.1%; 異動恆指及國指成份股: 藥明生物(02269.HK) 收77.1元,上升6.2%; 創科(00669.HK) 收103.5元,上升6.1%; 舜宇(02382.HK) 收101.3元,上升6%; 海爾智家(06690.HK) 收31元,上升4.9%; 聯想集團(00992.HK) 收6.1元,下跌3.5%; 新世界發展(00017.HK) 收23.05元,上升3.4%; 申洲(02313.HK) 收104.5元,上升3.3%; 恆地(00012.HK) 收28.7元,上升3.2%; 翰森製藥(03692.HK) 收17.58元,上升3.2%; 聯通(00762.HK) 收5.48元,上升2.4%,創新高; 國壽(02628.HK) 收15.06元,上升0.5%,創新高; 異動綜合中小型股: 榮暉國際(00990.HK) 收0.9元,上升20%; 藥明巨諾-B(02126.HK) 收6.25元,上升19%; 維亞生物(01873.HK) 收2.21元,上升18.2%; 美圖(01357.HK) 收1.7元,上升14.9%; 先健科技(01302.HK) 收3.19元,上升13.9%; 華興資本(01911.HK) 收10.82元,上升13.7%; 再鼎醫藥(09688.HK) 收37.1元,上升13.1%; 雲頂新耀-B(01952.HK) 收26.9元,上升12.8%; 諾輝健康(06606.HK) 收34.1元,上升12.5%; 瑞聲(02018.HK) 收19.78元,上升11.2%; 心通醫療(02160.HK) 收3.88元,上升10.9%; 環球新材國際(06616.HK) 收4.7元,上升10.8%; 藥明康德(02359.HK) 收108.6元,上升10.5%; 創維集團(00751.HK) 收5.34元,上升10.3%; 寶尊電商-W(09991.HK) 收21.2元,上升10.3%; 三葉草生物-B(02197.HK) 收3.02元,上升10.2%; 康基醫療(09997.HK) 收10.24元,上升7.1%,創新高; 亞盛醫藥(06855.HK) 收31.65元,上升7.1%,創新高; 綠葉製藥(02186.HK) 收4.34元,上升6.1%,創新高; ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account